Relapse in chronic myeloid leukemia after bone marrow transplantation: Biomathematical modeling as a new approach to understanding pathogenesis

Stem Cells

Volumn 17, Issue 1, 1999, Pages 9-17

  Vincent, P C ^c   Rutzen Loesevitz, L ^c   Tibken, B ^a   Heinze, B ^c   Hofer, E P ^a   Fliedner, Theodor M ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c NONE

Author keywords

Biomathematical modeling; Bone marrow transplantation; Chronic myeloid leukemia; Ph chromosome; Relapse

Indexed keywords

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CELL REGENERATION; CHRONIC MYELOID LEUKEMIA; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE COURSE; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GRANULOPOIESIS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METAPHASE CHROMOSOME; NEUTROPHIL; PHILADELPHIA 1 CHROMOSOME; PREDICTION; RELAPSE; TREATMENT OUTCOME;

EID: 0032920225     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.170009     Document Type: Article

References (27)

1. Vincent PC, Cronkite EP, Greenberg ML et al. Leukocyte kinetics in chronic myeloid leukemia: I. DNA synthesis time in blood and marrow myelocytes. Blood 1969;33:843-850.
2. Ogawa M, Fried J, Sakai Y et al. Studies of cell proliferation in human leukemia. VI. the proliferative activity, generation time, and emergence time of neutrophilic granulocytes in chronic granulocytic leukemia. Cancer 1970;25:1031-1049.
3. Vincent PC. Granulocyte kinetics in health and disease. Clin Haematol 1977;6:695-717.
4. Vincent PC. Kinetics of leukemia and control of cell division and replication. In: Henderson ES, Lister TA, eds. Leukemia. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: W.B. Saunders Company, 1990:55-104.
5. Heim S, Mitelman F. Cancer Cytogenetics. New York, Chichester, Brisbane, Toronto, Singapore: Wiley-Liss, 1995:33-68.
6. Champlin R, McGlave P. Allogeneic bone marrow transplantation for chronic myeloid leukemia. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. Boston: Blackwell Scientific Publications, 1994:595-606.
7. Hughes TP, Morgan GJ, Martiat P et al. Detection of residual leukemia after bone marrow transplant for chronic myeloid leukemia: role of polymerase chain reaction in predicting relapse. Blood 1991;77:874-878.
8. Delage R, Solffer RJ, Dear K et al. Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia. Blood 1991;78:2759-2767.
9. Arnold R, Bartram CR, Heinze B et al. Evaluation of remission state in chronic myeloid leukemia patients after bone marrow transplantation using cytogenetic and molecular genetic approaches. Bone Marrow Transplant 1989;4:389-392.
10. Arnold R, Janssen JWG, Heinze B et al. Influence of graft-versus-host disease on the eradication of minimal residual leukemia detected by polymerase chain reaction in chronic myeloid leukemia patients after bone marrow transplantation. Leukemia 1993;7:747-751.
11. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent myelogenous leukemia in marrow transplanted patients. Blood 1990;76:2462-2465.
12. Kolb H-J, Schattenberg A, Goldman JM et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995;86:2041-2050.
13. Heinze B, Arnold R, Kratt E et al. Clonal evolution of chromosomal anomalies in leukemic patients after bone marrow transplantation. In: Chadwick KH, Seymour C, Barnhart B et al., eds. Cell Transformation and Radiation-Induced Cancer. Bristol: Adam Hilger Ltd., 1989:177-184.
14. Heinze B, Bink K, Bunjes D et al. Relapse in CML after BMT: Chromosomal abnormalities in addition to the ph do not necessarily implicate the transformation of the disease. Ann Hematol 1996;3(suppl 2):450.
15. Fliedner TM, Steinbach K-H. Simulationsmodelle von Perturbationen des granulozytären Zellerneuerungssystems. In: Doerr W, Schipperges H, eds. Modelle der Pathologischen Physiologie. Berlin: Springer, 1987:89-106.
16. Fliedner TM, Steinbach K-H. Repopulating potential of hematopoietic precursor cells. Blood Cells 1988;14:393-410.
17. Tibken B, Hofer EP. A biomathematical model of granulocytopoiesis for estimation of stem cell numbers. STEM CELLS 1995;13(suppl 1):283-289.
18. Hoelzer D, Harriss EB. The failure of normal haematopoiesis in rats during the development of acute leukemia. Acta Haematol 1973;49:36-47.
19. Fliedner TM, Cronkite EP, Bond VP. Das Studium der Proliferationsdynamik der Myelopoese unter Verwendung der Einzelzellautoradiographie. Folia Haematologica 1961;6:210-228.
20. Killmann SA, Cronkite EP, Robertson JS et al. Estimation of the life cycle of leukemic cells from labeling in human beings in vivo with tritiated thymidine. Lab Invest 1963;12:671-684.
21. Buckner CD, Petersen FB, Bolonosi BA. Bone marrow donors. In: Forma SJ, Blume KG, Thomas ED, eds. Bone Marrow Tranplantation. Boston: Blackwell Scientific Publications, 1994;259-269.
22. Baum CM, Uchida N, Peault B et al. Isolation and characterization of hematopoietic progenitor and stem cells. In: Forman SJ, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. Boston: Blackwell Scientific Publications, 1994;53-71.
23. Muller-Bérat CN, Wantzin GL, Philip P et al. Agar culture studies of bone marrow, blood, spleen and liver in chronic myeloid leukemia. Leuk Res 1977;1:123-131.
24. Morris TCM, Vincent PC, Gunz FW et al. Evidence following splenic radiotherapy for a highly dynamic traffic of CFU-GM between the spleen and other organs in chronic granulocytic leukemia. Leuk Res 1987;11:109-117.
25. Bagby GC. Stem cell (CFU-C) proliferation and emergence in a case of chronic granulocytic leukemia: the role of the spleen. Scand J Haematol 1978;20:193-199.
26. Adler SS. The pathogenesis of spleen mediated phenomena in chronic myeloid leukemia and agnogenic myeloid metaplasia: a non abscopal mechanism. Scand J Haematol 1976;17:153-159.
27. Killmann SA. Acute leukemia: development, remission/relapse pattern, relationship between normal and leukemic hemopoiesis, and the 'sleeper-to-feeder' stem cell hypothesis. Series Haematol 1968;1:103-128.